{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:21Z","timestamp":1771002141953,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.expneurol.2007.09.012","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T20:47:35Z","timestamp":1191271655000},"page":"288-291","source":"Crossref","is-referenced-by-count":56,"title":["Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease"],"prefix":"10.1016","volume":"209","author":[{"given":"Attila D.","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2007.09.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2006.10.008","article-title":"Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII)","volume":"73","author":"Bialer","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.expneurol.2007.09.012_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjp.0707362","article-title":"Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models","volume":"152","author":"Gigler","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2007.09.012_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/088307389501000602","article-title":"The neuronal ceroid-lipofuscinoses","volume":"10","author":"Goebel","year":"1995","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.expneurol.2007.09.012_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2007.09.012_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2005.06.031","article-title":"The effects of AMPA receptor antagonists in models of stroke and neurodegeneration","volume":"519","author":"Gressens","year":"2005","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.expneurol.2007.09.012_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2007.09.012_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nbd.2005.12.018","article-title":"Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease","volume":"22","author":"Kov\u00e1cs","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.09.012_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200059010-00004","article-title":"Pharmacology of AMPA\/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders","volume":"59","author":"Lees","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.expneurol.2007.09.012_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainres.2004.05.098","article-title":"Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia","volume":"1019","author":"Matucz","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2007.09.012_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2007.09.012_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3\u2212\/\u2212 mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2007.09.012_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0361-9230(01)00516-0","article-title":"Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655","volume":"55","author":"Szabados","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2007.09.012_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","author":"The International Batten Disease Consortium","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2007.09.012_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuint.2006.11.003","article-title":"The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA\/kainate ion channels and cell death","volume":"50","author":"V\u00e9gh","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2007.09.012_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/mgme.2000.3057","article-title":"Neuronal ceroid lipofuscinoses and possible pathogenic mechanism","volume":"71","author":"Zhong","year":"2000","journal-title":"Mol. Genet. Metab."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607003615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T21:20:08Z","timestamp":1546550408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607003615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0014488607003615"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.09.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}